Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Pacific Therapeutics reports encouraging phase I results with combination treatment for fibrosis

Nov. 15, 2012

Researchers at Reata Pharmaceuticals prepare new NO production inhibitors

Oct. 16, 2012

Biotie Therapies describes novel SSAO inhibitors

Oct. 2, 2012

Korean researchers patent new fusion proteins for fibrosis

Sep. 27, 2012

Pacific Therapeutics advances first-in-human trial of repurposed combination

Aug. 24, 2012

Spanish group synthesizes novel anti-inflammatory agents

July 30, 2012

Reata Pharmaceuticals presents new inhibitors of NO production

July 17, 2012

RNAi screen identifies targets for diseases involving protein misfolding

Jan. 13, 2012

Celtaxsys obtains anti-inflammatory drug from Estrellita Pharmaceuticals

Jan. 12, 2012

Novel anti-inflammatory agents discovered in U.K.

Jan. 11, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....